ALTO-100 in MDD and/or PTSD

Clinical trial NCT05117632 · COMPLETED

Trial details

NCT number: NCT05117632
Sponsor: Alto Neuroscience
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder Post Traumatic Stress Disorder

Start date: 2021-12-20
Primary completion: 2022-12-01
Enrollment: 245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.